Athersys, Inc. (NASDAQ: ATHX) Athersys is having an incredible day in the market today, and for good reason. Early this morning, the company released positive news that it received from the United States Food and Drug Administration. Today, we’ll talk about the news, what we’re seeing from the stock as a result, and what we … Read more
Athersys, Inc (NASDAQ: ATHX) Athersys is having an incredibly strong day in the market today, and for good reason. The company released data from a Phase 2 clinical trial looking into MultiStem cell therapy which proved to be incredibly positive. Today, we’ll take a look at the results that were released, how the market reacted … Read more
Athersys, Inc. (NASDAQ: ATHX) Athersys is having a great day in the market today after announcing that a partnership agreement has been signed with Healios. Today, we’ll discus the details of the partnership agreement, what we’re seeing from ATHX in the market as a result, and what we can expect to see from the stock … Read more
Athersys, Inc. (NASDAQ: ATHX) As expected Athersys recently reported their earnings for the first quarter. Unfortunately, the report wasn’t what we expected to see. As a result, we saw a steep decline in the value of the stock earlier this morning, followed by a correction that brought the value back up. So today, we’ll talk … Read more
Athersys, Inc. (NASDAQ: ATHX) On Friday, ATHX fell hard after releasing phase II study of MultiStem cell therapy for treatment of ischemic stroke data. The data showed that the treatment missed both primary and secondary end points; providing absolutely no benefit after 90 when compared to a placebo. As a result, the stock fell to … Read more
Athersys, Inc. (NASDAQ: ATHX) Athersys has a big day coming on the 19th. As mentioned in a previous post, the company will be releasing the results of the last clinical trial for their MultiStem treatment. The treatment is expected to help patients recover from stroke more quickly. However, it doesn’t seem as though investors are … Read more
Athersys, Inc. (NASDAQ: ATHX) Athersys, Inc. stock recently climbed following an announcement that they would provide Phase 2 data from a new treatment on April 19th at the European Stroke Organization Conference. After the climb, the stock started to reach resistance as investors started to think about what the presentation means. In all reality, on … Read more
Athersys, Inc. (NASDAQ: ATHX) Athersys had an incredible day in the market yesterday; climbing by more than 10% on positive news. However, today the story seems to be a bit different. After a sharp morning peak, it seems as though the stock has hit a bit of resistance. However, the sky isn’t falling. In the … Read more
US stocks are down overall today for the third day in a row today; with today’s drop looking to be the steepest for many. Before the closing bell today, it was announced that orders for durable goods fell dramatically in the month of February; marking the third month out of the last four that we’ve … Read more